The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene
Authors
Keywords
-
Journal
ONCOGENE
Volume 30, Issue 25, Pages 2810-2822
Publisher
Springer Nature
Online
2011-02-14
DOI
10.1038/onc.2011.8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
- (2010) Yang Wang et al. CANCER SCIENCE
- Upstream Regulation of the Hippo Size Control Pathway
- (2010) Felix A. Grusche et al. CURRENT BIOLOGY
- Structural basis of YAP recognition by TEAD4 in the Hippo pathway
- (2010) L. Chen et al. GENES & DEVELOPMENT
- Structural insights into the YAP and TEAD complex
- (2010) Z. Li et al. GENES & DEVELOPMENT
- A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF -TRCP
- (2010) B. Zhao et al. GENES & DEVELOPMENT
- Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
- (2010) Gillian L. Dalgliesh et al. NATURE
- Structural and functional analysis of the YAP-binding domain of human TEAD2
- (2010) W. Tian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis
- (2010) K.-P. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Frequent loss of heterozygosity and altered expression of the candidate tumor suppressor gene 'FAT' in human astrocytic tumors
- (2009) Kunzang Chosdol et al. BMC CANCER
- Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma
- (2009) Michelle Z. Xu et al. CANCER
- Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene
- (2009) Dawang Zhou et al. CANCER CELL
- Transcriptional Output of the Salvador/Warts/Hippo Pathway Is Controlled in Distinct Fashions in Drosophila melanogaster and Mammalian Cell Lines
- (2009) X. Zhang et al. CANCER RESEARCH
- YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation
- (2009) A. Fernandez-L et al. GENES & DEVELOPMENT
- The Emerging Role of the Hippo Pathway in Cell Contact Inhibition, Organ Size Control, and Cancer Development in Mammals
- (2008) Qi Zeng et al. CANCER CELL
- A Role for TAZ in Migration, Invasion, and Tumorigenesis of Breast Cancer Cells
- (2008) S. W. Chan et al. CANCER RESEARCH
- Negative Regulation of YAP by LATS1 Underscores Evolutionary Conservation of the Drosophila Hippo Pathway
- (2008) J. Zhang et al. CANCER RESEARCH
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling
- (2008) M. Ota et al. DEVELOPMENT
- Expression of Yes-associated protein in common solid tumors
- (2008) Angela A. Steinhardt et al. HUMAN PATHOLOGY
- Identification of Fat4 as a candidate tumor suppressor gene in breast cancers
- (2008) Chao Qi et al. INTERNATIONAL JOURNAL OF CANCER
- Mst2 and Lats Kinases Regulate Apoptotic Function of Yes Kinase-associated Protein (YAP)
- (2008) Tsutomu Oka et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo Pathway
- (2008) Q.-Y. Lei et al. MOLECULAR AND CELLULAR BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started